Ashland has introduced vialose sucrose, a high purity sucrose for parenteral formulations that’s designed to protect and shield biologic molecules in injectables. Vialose sucrose meets the lowest levels of endotoxins (<0.2 g/EU) and meets NF, EP, JP, BP and ChP monograph specifications.  The addition of sucrose expands Ashland’s portfolio of vialose high purity sugar excipients, which includes trehalose dihydrate. These sugars are used in medicines as lyoprotectants and for pro...